Comparative trial in hormone withdrawal associated symptoms

• Research type

  Research Study

• Full title

  A multi-centre, randomised, double-blind, active control, parallel-group, 2-arm study to investigate the effect of ethinylestradiol / drospirenone (0.02 mg/3 mg) oral contraception in a 24/4 regimen compared to ethinylestradiol / desogestrel (0.02 mg/0.15 mg) oral contraception in a 21/7 regimen on hormone withdrawal associated symptoms in otherwise healthy women after 4 cycles of treatment

• IRAS ID

  37870

• Contact name

  Nick Panay

• Contact email

  nickpanay@msn.com

• Sponsor organisation

  Bayer HealthCare AG

• Eudract number

  2009-014911-11

• ISRCTN Number

  Not available

• Research summary

  Exceeds word count do not publish

• REC name

  North East - Tyne & Wear South Research Ethics Committee

• REC reference

  10/H0904/10

• Date of REC Opinion

  20 Apr 2010

• REC opinion

  Further Information Favourable Opinion